Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Central Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT00627029
What this trial is testing

Evaluation of Programs of Coordinated Care and Disease Management

Who this might be right for
Congestive Heart FailureDiabetesCoronary Artery Disease+6 more
Mathematica Policy Research, Inc. 18,277
Testing effectiveness (Phase 2)Looking for participantsNCT06445881
What this trial is testing

Efficacy and Safety of Modified Si Jun Zi Tang in Perioperative NSCLC Treatment

Who this might be right for
Non Small Cell Lung CancerPerioperative Complication
First Affiliated Hospital of Zhejiang University 60
Testing effectiveness (Phase 2)Looking for participantsNCT07206498
What this trial is testing

Evaluate Safety and Efficacy of WSD0922-FU Combo With Osimertinib for NSCLC

Who this might be right for
Non Small Cell Lung Cancer (NSCLC)
Wayshine Biopharm, Inc. 48
Testing effectiveness (Phase 2)Looking for participantsNCT05503667
What this trial is testing

Neoadjuvant Furmonertinib Plus Bevacizumab or Furmonertinib Monotherapy for Resectable and Potentially Resectable Stage III-IVA EGFR Mutation-Positive Lung Adenocarcinoma

Who this might be right for
Lung Adenocarcinoma Stage IIILung Adenocarcinoma Stage IVEGFR Gene Mutation
Shanghai Pulmonary Hospital, Shanghai, China 96
Not applicableStudy completedNCT01385111
What this trial is testing

Combined Application of EBUS and EUS in Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
National Cancer Center, Korea 162
Not applicableWithdrawnNCT03041571
What this trial is testing

Impact of Early Implementation of Narrative Medicine Techniques on Patient Centered Attitudes of Medical Students

Who this might be right for
Narrative MedicineChronic DiseaseTerminal Illness+6 more
University of Florida
Not applicableUnknownNCT00591552
What this trial is testing

Use of Harmonic Scalpel to Decrease Lymphatic and Chest Tube Drainage After Lymph Node Dissection With Lobectomy.

Who this might be right for
Lung Cancer
Sentara Cardiovascular Research Institute 50
Not applicableStudy completedNCT06900114
What this trial is testing

Disease Burden Transition of Mucormycosis in Hematologic Malignancies Population Across Covid 19 Era: a Single-center Comparative Analysis From China

Who this might be right for
MucormycosisHematologic MalignanciesCOVID-19
Institute of Hematology & Blood Diseases Hospital, China 60
Large-scale testing (Phase 3)Active Not RecruitingNCT03164616
What this trial is testing

Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON).

Who this might be right for
Non Small Cell Lung Cancer NSCLC
AstraZeneca 1,186
Not applicableLooking for participantsNCT06483698
What this trial is testing

Real-world Clinical Outcomes of Patients With Early-stage Lung Cancer After the Surgery

Who this might be right for
Lung Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 20,000
Early research (Phase 1)Ended earlyNCT05397093
What this trial is testing

ITIL-306 in Advanced Solid Tumors

Who this might be right for
Epithelial Ovarian CancerNon-small Cell Lung CancerRenal Cell Carcinoma
Instil Bio 1
Testing effectiveness (Phase 2)Study completedNCT03520842
What this trial is testing

Regorafenib and Methotrexate in Treating Participants With Recurrent or Metastatic KRAS Mutated Non-Small Cell Lung Cancer

Who this might be right for
KRAS Gene MutationMetastatic Malignant Neoplasm in the BrainRecurrent Non-Small Cell Lung Carcinoma+1 more
Stanford University 22
Large-scale testing (Phase 3)Study completedNCT04923945
What this trial is testing

Savolitinib for Treating Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Patients

Who this might be right for
Non-small Cell Lung Cancer Metastatic
Hutchison Medipharma Limited 203
Early research (Phase 1)Active Not RecruitingNCT07709637
What this trial is testing

Evaluation of Safety, Tolerance, and Efficacy of Allogeneic LB-DTK-COV19 in Severe Coronavirus Disease 2019 Patients

Who this might be right for
COVID-19COVID-19 (SARS-CoV-2 Infection)
LucasBio 1
Large-scale testing (Phase 3)Study completedNCT01326767
What this trial is testing

Central European Society for Anticancer Research (CESAR) Study of Paclitaxel Therapeutic Drug Monitoring

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Central European Society for Anticancer Drug Research 366
Large-scale testing (Phase 3)Study completedNCT05807893
What this trial is testing

Study to Evaluate the Safety and Efficacy of Serplulimab Plus Bevacizumab and Chemotherapy in NSCLC Patients With Brain Metastases

Who this might be right for
Non-small Cell Lung Cancer Stage IIBevacizumabImmunotherapy+1 more
Sun Yat-sen University 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03157128
What this trial is testing

Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)

Who this might be right for
Non-Small Cell Lung CancerMedullary Thyroid CancerColon Cancer+1 more
Eli Lilly and Company 857
Not applicableStudy completedNCT04890028
What this trial is testing

Detection and Metabolic Characterization in DOPA PET/CT of Brain Metastases

Who this might be right for
Brain MetastasesMRI
Institut Cancerologie de l'Ouest 32
Not applicableEnrolling By InvitationNCT06812767
What this trial is testing

Risk Factors at Chronic Non-communicable Diseases in People of Working Age

Who this might be right for
Chronic Non-communicable Disease
National Medical Research Center for Therapy and Preventive Medicine 2,000
Not applicableStudy completedNCT07073898
What this trial is testing

UG3 Pilot Clinical Trial

Who this might be right for
Lung Cancer
University of Utah 65
Next Page